Meghan O'Connell1, Sangchoon Jeon, Samantha Conley, Sarah Linsky, Nancy S Redeker. 1. Meghan O'Connell, MPH Program Manager, School of Nursing, University of Connecticut, Storrs, Connecticut. Sangchoon Jeon, PhD Senior Research Scientist/Biostatistician, Yale School of Nursing, West Haven, Connecticut. Samantha Conley, PhD, RN Nurse Scientist, The Mayo Clinic, Rochester, Minnesota. Sarah Linsky, MPH Research Assistant, Yale School of Nursing, West Haven, Connecticut. Nancy S. Redeker, PhD, RN Professor, School of Nursing, University of Connecticut, Storrs, Connecticut.
Abstract
BACKGROUND: The COVID-19 pandemic raised concerns about the effects of stress on sleep and mental health, particularly among people with chronic conditions, including people with heart failure (HF). OBJECTIVE: The aim of this study was to examine changes in sleep, sleep-related cognitions, stress, anxiety, and depression among people with HF who participated in a randomized controlled trial of cognitive behavioral therapy for insomnia before the COVID-19 pandemic. METHODS: Participants self-reported sleep characteristics, symptoms, mood, and stress at baseline, 6 months after cognitive behavioral therapy for insomnia or HF self-management education (attention control), and during the pandemic. RESULTS: The sample included 112 participants (mean age, 63 ± 12.9 years; 47% women; 13% Black; 68% New York Heart Association class II or III). Statistically significant improvements in sleep, stress, mood, and symptoms that occurred 6 months post treatment were sustained during the pandemic. CONCLUSIONS: Improving sleep and symptoms among people with HF may improve coping during stressful events, and cognitive behavioral therapy for insomnia may be protective.
BACKGROUND: The COVID-19 pandemic raised concerns about the effects of stress on sleep and mental health, particularly among people with chronic conditions, including people with heart failure (HF). OBJECTIVE: The aim of this study was to examine changes in sleep, sleep-related cognitions, stress, anxiety, and depression among people with HF who participated in a randomized controlled trial of cognitive behavioral therapy for insomnia before the COVID-19 pandemic. METHODS: Participants self-reported sleep characteristics, symptoms, mood, and stress at baseline, 6 months after cognitive behavioral therapy for insomnia or HF self-management education (attention control), and during the pandemic. RESULTS: The sample included 112 participants (mean age, 63 ± 12.9 years; 47% women; 13% Black; 68% New York Heart Association class II or III). Statistically significant improvements in sleep, stress, mood, and symptoms that occurred 6 months post treatment were sustained during the pandemic. CONCLUSIONS: Improving sleep and symptoms among people with HF may improve coping during stressful events, and cognitive behavioral therapy for insomnia may be protective.
Authors: Nancy S Redeker; Andrea K Knies; Christopher Hollenbeak; H Klar Yaggi; John Cline; Laura Andrews; Daniel Jacoby; Anna Sullivan; Meghan O'Connell; Joanne Iennaco; Lisa Finoia; Sangchoon Jeon Journal: Contemp Clin Trials Date: 2017-01-31 Impact factor: 2.226
Authors: Allison E Gaffey; Sangchoon Jeon; Samantha Conley; Daniel Jacoby; Garrett I Ash; Henry K Yaggi; Meghan O'Connell; Sarah J Linsky; Nancy S Redeker Journal: Behav Sleep Med Date: 2020-05-12 Impact factor: 2.964